313 results
8-K
EX-99.1
AWH
Aspira Women`s Health Inc
15 May 24
Aspira Women’s Health Reports First Quarter 2024 Financial Results
8:00am
-risk.
Announced a new agreement with Anthem Blue Cross in California for reimbursement coverage of the Company’s OvaSuite portfolio of risk assessment
DEFA14A
AWH
Aspira Women`s Health Inc
9 May 24
Additional proxy soliciting materials
6:39pm
.
“Reimbursement” shall have the meaning set forth in Section 5.14.
“Rescission” shall have the meaning set forth in Section 5.13.
“Restricted Stock … shall be entitled to indemnification and reimbursement by the Company in respect of any claim, loss, damage or expense (including attorneys’ fees
424B5
AWH
Aspira Women`s Health Inc
26 Apr 24
Prospectus supplement for primary offering
5:29pm
the size of the markets for our products;
expectations regarding reimbursement for our products, and our ability to obtain such reimbursement, from third … the volume of our product sales; failures by third-party payers to reimburse for our products and services or changes to reimbursement rates; our ability
8-K
EX-99.1
rt49hsq 1vahf1
28 Mar 24
Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results
4:50pm
8-K
EX-10.1
98ak8l56 eo5z6s
21 Mar 24
Departure of Directors or Certain Officers
4:10pm
8-K/A
EX-10.1
b284g
26 Jan 24
Entry into a Material Definitive Agreement
5:19pm
8-K/A
EX-1.1
m1yjmmc
26 Jan 24
Entry into a Material Definitive Agreement
5:19pm
424B5
9x4rd tuae3n6e65l
26 Jan 24
Prospectus supplement for primary offering
5:12pm
8-K
EX-1.1
6tn7uo
25 Jan 24
Entry into a Material Definitive Agreement
5:31pm
8-K
EX-10.1
rg8nh jvvpw
25 Jan 24
Entry into a Material Definitive Agreement
5:31pm
8-K
EX-99.1
2kwy 3zushgwy9dyr215
6 Dec 23
Aspira Women’s Health Provides a Development Update on its Portfolio of Noninvasive Tests for Endometriosis
4:43pm
8-K
EX-99.1
gcveo h5diw
13 Nov 23
Aspira Women’s Health Reports Third Quarter 2023 Financial Results
4:13pm